Potent chemical chaperone compounds for GM1-gangliosidosis: N-substituted (+)-conduramine F-4 derivatives
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Potent chemical chaperone compounds for GM1-gangliosidosis: N-substituted (+)-conduramine F-4 derivatives
Authors
Keywords
-
Journal
MedChemComm
Volume 6, Issue 2, Pages 306-310
Publisher
Royal Society of Chemistry (RSC)
Online
2014-11-04
DOI
10.1039/c4md00270a
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Structural Basis of Pharmacological Chaperoning for Human β-Galactosidase
- (2014) Hironori Suzuki et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Pharmacological Chaperones as Therapeutics for Lysosomal Storage Diseases
- (2013) Robert E. Boyd et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Bicyclic 1-Deoxygalactonojirimycin Derivative as a Novel Pharmacological Chaperone for GM1 Gangliosidosis
- (2013) Tomoko Takai et al. MOLECULAR THERAPY
- Concise syntheses of potent chaperone drug candidates, N-octyl-4-epi-β-valinenamine (NOEV) and its 6-deoxy derivative, from (+)-proto-quercitol
- (2012) Shinichi Kuno et al. CARBOHYDRATE RESEARCH
- Tuning glycosidase inhibition through aglycone interactions: pharmacological chaperones for Fabry disease and GM1 gangliosidosis
- (2012) M. Aguilar-Moncayo et al. CHEMICAL COMMUNICATIONS
- Discovery, Structure–Activity Relationship, and Biological Evaluation of Noninhibitory Small Molecule Chaperones of Glucocerebrosidase
- (2012) Samarjit Patnaik et al. JOURNAL OF MEDICINAL CHEMISTRY
- Evaluation of N-nonyl-deoxygalactonojirimycin as a pharmacological chaperone for human GM1 gangliosidosis leads to identification of a feline model suitable for testing enzyme enhancement therapy
- (2012) Brigitte A. Rigat et al. MOLECULAR GENETICS AND METABOLISM
- Pharmacological Enhancement of α-Glucosidase by the Allosteric Chaperone N-acetylcysteine
- (2012) Caterina Porto et al. MOLECULAR THERAPY
- Determining the Role of the Aromatic Ring ofN-Arylmethylent-conduramine F-1 in their Interactions with α-Glucosidases by Saturation Transfer Difference NMR Spectroscopy Experiments
- (2012) Antonio Hernández Daranas et al. ChemistryOpen
- Identification and Characterization of Pharmacological Chaperones to Correct Enzyme Deficiencies in Lysosomal Storage Disorders
- (2011) Kenneth J. Valenzano et al. ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES
- 1-Deoxy-d-galactonojirimycins with dansyl capped N-substituents as β-galactosidase inhibitors and potential probes for GM1 gangliosidosis affected cell lines
- (2011) Richard F.G. Fröhlich et al. CARBOHYDRATE RESEARCH
- Chemical chaperone therapy: chaperone effect on mutant enzyme and cellular pathophysiology in β-galactosidase deficiency
- (2011) Katsumi Higaki et al. HUMAN MUTATION
- DLHex-DGJ, a novel derivative of 1-deoxygalactonojirimycin with pharmacological chaperone activity in human GM1-gangliosidosis fibroblasts
- (2010) Katrin Fantur et al. MOLECULAR GENETICS AND METABOLISM
- (+)-proto-Quercitol, a natural versatile chiral building block for the synthesis of the α-glucosidase inhibitors, 5-amino-1,2,3,4-cyclohexanetetrols
- (2009) Sumrit Wacharasindhu et al. TETRAHEDRON LETTERS
- A counterintuitive approach to treat enzyme deficiencies: use of enzyme inhibitors for restoring mutant enzyme activity
- (2007) Jian-Qiang Fan BIOLOGICAL CHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now